On or around 12/27/2016 (Date of order of final judgment)
Filing Date: February 24, 2016
According to the Complaint, it is alleged that the consideration Affymetrix’s stockholders stand to receive in connection with the Proposed Transaction and the process by which Defendants propose to consummate the Proposed Transaction are fundamentally unfair to Plaintiff and the other common stockholders of Affymetrix.
The parties filed a Stipulation of Settlement on July 29, 2016. The Settlement was preliminarily approved on September 21. The Settlement was granted final approval and this case was dismissed on December 27.
Company & Securities Information
Defendant: Affymetrix, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: AFFX
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Gerald Douglas, et al. v. Affymetrix, Inc., et al.